This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Annual Congress on Research and Innovations in Medicine July 02-03, 2018 Bangkok, Thailand
Theme: Current Research and Innovations in Medicine to Improve Human Health
July 02-03, 2018 Bangkok, Thailand
International Conference on Medical and Health Science August 24-25, 2018 Tokyo, JAPAN
Theme: Scrutinize the Modish of Medical and Health Science
August 24-25, 2018 Tokyo, Japan
World Summit on Trauma and Reconstructive Surgery Sep 10-11, 2018 Singapore
Theme: Expanding new horizons in Trauma and Surgery
Sep 10-11, 2018 Singapore City, Singapore
6th American Gynecological Surgery Conference September 28-29, 2018 San Antonio | Texas | USA
September 28-29, 2018 San Antonio, USA
World Congress on Fetal and Maternal Medicine October 15-17, 2018 Osaka, Japan
Theme: A New Beginning on Fetal, Maternal & Neonatal Medicine
October 15-17, 2018 Osaka, Japan
International Conference on Reproduction and Fertility October 18-19, 2018 Abu Dhabi, UAE
October 18-19, 2018 Abu Dhabi, UAE
Assistant Professor, Department of Obstetrics and Gynecology, The University of Texas Health Science Center, USA.
Nameer Kirma received his PhD in molecular biology from Georgia State University, Atlanta, Georgia in 1997. His postdoctoral work in the department of Obstetrics and Gynecology at Emory University focused on estrogen actions in breast cancer. He later attained instructor positions in OB/GYN and Endocrinology at Emory University. Dr. Kirma then moved to the Department of OB/GYN at the University of Texas Health Science Center at San Antonio in 2004 as assistant professor. His current research focuses on the role of signaling factors as well as nutritional effects on inflammatory gynecological diseases, such as endometriosis, and women related malignancies. He has published in peer review journals such as Cancer Research and Molecular Human Reproduction.
Two main lines of research are currently the main focus of my laboratory. The first is the role of dietary intervention, specifically phytoestrogens, on breast cancer risk. Mouse models of breast cancer are used for this research. The second line of research is the role of cell signaling, pharmacological modulation and natural compounds in benign and malignant gynecologic diseases. Established cell culture systems, primary tissue as well as mouse models are used for this research.